Joshua Bernstein, MD
Nephrology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 25 years
- University of Vermont College of Medicine, 2001
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: 552794 · Marinhealth Medical Center · Novato Community Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bernstein’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A99752 · Current
Licensed to practise in California · since 2007 · expires 2027-03-31 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$116,838
Medicare paid this office $116,838 for 313 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $47,233 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $15,910 | $154 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 29 | $14,490 | $329 |
| New patient visit (60+ min) | 42 | $8,930 | $213 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $6,586 | $274 |
See all 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $47,233 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $15,910 | $154 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 29 | $14,490 | $329 |
| New patient visit (60+ min) | 42 | $8,930 | $213 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $6,586 | $274 |
| Long return visit (40+ min) | 25 | $5,454 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,864 | $72 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,919 | $104 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $2,880 | $192 |
| Return visit (30+ min) | 13 | $2,016 | $126 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $741 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $625 | $45 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 33 | $533 | $15 |
Who their Medicare patients are
313 Original Medicare patients in 2024. Average age 77 · Under 65 13% · 85 and older 25% · Women 45% · Also on Medicaid 43% · Health risk score 3.66. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Coronary heart disease 49% · Diabetes 48% · Heart failure 47% · Atrial fibrillation 39% · Depression 36% · Cancer 24% · COPD 24% · Dementia 22% · Stroke 22%.
The office billed $604,004, Medicare allowed $145,511 and paid $116,838; for 976 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 313 | 976 | 77 | 3.66 | $604,004 | $116,838 |
| 2023 | 255 | 574 | 78 | 2.58 | $327,243 | $65,109 |
| 2022 | 244 | 642 | 76 | 2.67 | $295,613 | $64,736 |
| 2021 | 350 | 1,607 | 74 | 3.79 | $308,800 | $193,851 |
| 2020 | 358 | 1,374 | 75 | 3.53 | $259,065 | $160,594 |
| 2019 | 384 | 1,936 | 75 | 4.05 | $311,460 | $198,909 |
| 2018 | 364 | 1,473 | 74 | 3.91 | $274,875 | $171,616 |
| 2017 | 348 | 1,984 | 74 | 4.24 | $294,345 | $188,434 |
| 2016 | 376 | 2,418 | 73 | 4.03 | $332,085 | $217,396 |
| 2015 | 341 | 2,432 | 72 | 4.87 | $312,620 | $204,396 |
| 2014 | 303 | 2,975 | 72 | 3.95 | $327,085 | $208,322 |
| 2013 | 319 | 2,448 | 72 | 4.45 | $276,700 | $175,125 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $36,407 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $16,928 | $154 |
| Hospital discharge day management, more than 30 minutes | 69 | $7,188 | $103 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 25 | $1,443 | $52 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $37,538 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $12,493 | $176 |
| Hospital discharge day management, more than 30 minutes | 83 | $7,935 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,483 | $64 |
| Hospital observation care on day of discharge | 11 | $781 | $65 |
2021: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $49,679 | $92 |
| Long return visit (40+ min) | 94 | $30,310 | $167 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $23,276 | $323 |
| Return visit (30+ min) | 96 | $18,118 | $117 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $16,604 | $272 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $14,606 | $178 |
| Telephone medical discussion with physician, 21-30 minutes | 61 | $10,626 | $114 |
| New patient visit (60+ min) | 28 | $5,445 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,162 | $62 |
| Short return visit (20+ min) | 19 | $1,608 | $80 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,582 | $66 |
| Manual urinalysis test with examination using microscope, non-automated | 28 | $113 | $4 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 139 | $50,284 | $95 |
| Long return visit (40+ min) | 80 | $16,892 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $16,446 | $185 |
| Return visit (30+ min) | 105 | $14,860 | $98 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $12,796 | $267 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $10,743 | $224 |
| New patient visit (60+ min) | 38 | $6,697 | $176 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $4,008 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 36 | $2,984 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,642 | $66 |
| Short return visit (20+ min) | 28 | $2,388 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $928 | $36 |
| Manual urinalysis test with examination using microscope, non-automated | 40 | $160 | $4 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 161 | $72,428 | $93 |
| Long return visit (40+ min) | 114 | $32,070 | $134 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $21,487 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $17,634 | $182 |
| Return visit (30+ min) | 113 | $14,964 | $98 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $12,295 | $256 |
| New patient visit (60+ min) | 39 | $7,324 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,831 | $64 |
| Short return visit (20+ min) | 17 | $1,370 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,302 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 47 | $189 | $4 |
2018: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $47,637 | $92 |
| Long return visit (40+ min) | 127 | $29,972 | $128 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $19,170 | $256 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $18,975 | $216 |
| Return visit (30+ min) | 106 | $13,748 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $12,858 | $176 |
| New patient visit (60+ min) | 55 | $9,844 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,523 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,330 | $121 |
| Short return visit (20+ min) | 11 | $752 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $554 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 62 | $248 | $4 |
2017: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $53,030 | $92 |
| Long return visit (40+ min) | 128 | $32,257 | $129 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $25,690 | $257 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $20,790 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $13,932 | $176 |
| Return visit (30+ min) | 77 | $9,451 | $95 |
| New patient visit (60+ min) | 42 | $7,825 | $186 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $4,289 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $3,044 | $122 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 13 | $2,595 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,585 | $65 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 12 | $1,455 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $906 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 44 | $200 | $4 |
2016: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $70,895 | $93 |
| Long return visit (40+ min) | 135 | $39,599 | $130 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 21 | $33,372 | $259 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $17,310 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $14,150 | $181 |
| New patient visit (60+ min) | 61 | $11,533 | $189 |
| Return visit (30+ min) | 60 | $7,904 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $2,078 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,070 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $842 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 57 | $237 | $4 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 182 | $75,768 | $94 |
| Long return visit (40+ min) | 94 | $30,447 | $132 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $25,900 | $259 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $17,960 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,624 | $182 |
| Return visit (30+ min) | 65 | $8,840 | $99 |
| New patient visit (60+ min) | 31 | $5,841 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,323 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $3,314 | $123 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 16 | $3,194 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $770 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 29 | $127 | $4 |
2014: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $71,767 | $91 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $43,569 | $252 |
| Long return visit (40+ min) | 65 | $20,454 | $129 |
| Return visit (30+ min) | 97 | $15,306 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $14,342 | $177 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $13,045 | $214 |
| New patient visit (60+ min) | 44 | $8,140 | $185 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 16 | $5,290 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,269 | $63 |
| Short return visit (20+ min) | 14 | $1,147 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $580 | $34 |
| Manual urinalysis test with examination using microscope, non-automated | 41 | $178 | $4 |
2013: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 169 | $52,420 | $90 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 21 | $40,488 | $255 |
| Return visit (30+ min) | 92 | $15,177 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,953 | $176 |
| Long return visit (40+ min) | 59 | $14,128 | $130 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $8,647 | $216 |
| New patient visit (60+ min) | 37 | $6,743 | $182 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 14 | $3,171 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $2,580 | $63 |
| Short return visit (20+ min) | 13 | $916 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $644 | $34 |
| Manual urinalysis test with examination using microscope, non-automated | 39 | $167 | $4 |
Medicaid work
$16,112 in 2024
Medicaid paid $16,112 for 85 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 33 | $13,102 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $2,163 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $847 |
| 2024 | 85 | 3 | 17 | $16,112 |
| 2023 | 257 | 2 | 17 | $20,790 |
| 2022 | 61 | 1 | 15 | $5,144 |
| 2021 | 216 | 1 | 17 | $12,706 |
| 2020 | 233 | 1 | 18 | $15,291 |
| 2019 | 193 | 1 | 20 | $7,529 |
| 2018 | 75 | 1 | 12 | $2,933 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 231 | $19,392 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $1,398 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 61 | $5,144 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 216 | $12,706 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 233 | $15,291 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 193 | $7,529 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 75 | $2,933 |
Drugs they prescribed that Part D paid
$28,032
Pharmacies billed $28,032 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
134 generic and 23 brand-name prescriptions · $28,032 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 157 | 61 | None | 15% | $28,032 |
| 2023 | 116 | 58 | None | None | $9,616 |
| 2022 | 567 | 166 | None | 14% | $48,607 |
| 2021 | 1,389 | 215 | None | None | $193,230 |
| 2020 | 1,330 | 199 | None | None | $143,962 |
| 2019 | 1,319 | 196 | None | None | $160,681 |
| 2018 | 1,469 | 215 | 1% (15) | 15% | $199,824 |
| 2017 | 1,658 | 181 | 1% (16) | 17% | $257,174 |
| 2016 | 1,552 | 167 | 1% (14) | 18% | $212,544 |
| 2015 | 1,352 | 146 | 2% (27) | None | $153,959 |
| 2014 | 1,308 | 137 | 3% (33) | None | $163,030 |
| 2013 | 1,131 | 117 | 4% (42) | 26% | $106,068 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 14 drugs
| Tacrolimus | 11 | $3,679 | $334 |
| Prosol | 30 | $3,333 | $111 |
| Tamsulosin | 28 | $614 | $22 |
| Torsemide | 12 | $510 | $43 |
| Amlodipine Besylate | 66 | $473 | $7 |
| Losartan | 30 | $458 | $15 |
| Hydralazine | 12 | $453 | $38 |
| Metoprolol | 13 | $367 | $28 |
| Famotidine | 13 | $321 | $25 |
| Allopurinol | 23 | $320 | $14 |
| Calcitriol | 15 | $309 | $21 |
| Furosemide | 26 | $297 | $11 |
| Atorvastatin | 21 | $245 | $12 |
| Lisinopril | 21 | $172 | $8 |
2021: 27 drugs
| Procrit | 17 | $30,957 | $1,821 |
| Lokelma | 18 | $17,794 | $989 |
| Jardiance | 13 | $16,355 | $1,258 |
| Calcium Acetate | 40 | $6,118 | $153 |
| Dexilant | 13 | $5,274 | $406 |
| Sevelamer Carbonate | 11 | $3,574 | $325 |
| Torsemide | 54 | $2,377 | $44 |
| Prosol | 16 | $1,962 | $123 |
| Labetalol | 20 | $1,777 | $89 |
| Metoprolol | 51 | $1,521 | $30 |
| Calcitriol | 39 | $1,498 | $38 |
| Tamsulosin | 53 | $1,336 | $25 |
| Famotidine | 50 | $1,315 | $26 |
| Allopurinol | 62 | $1,290 | $21 |
| Amlodipine Besylate | 156 | $1,270 | $8 |
| Diltiazem 24hr Er (Cd) | 20 | $913 | $46 |
| Furosemide | 94 | $860 | $9 |
| Hydralazine | 40 | $824 | $21 |
| Chlorthalidone | 38 | $801 | $21 |
| Losartan | 57 | $755 | $13 |
| Lisinopril | 78 | $698 | $9 |
| Atorvastatin | 26 | $483 | $19 |
| Spironolactone | 30 | $440 | $15 |
| Gabapentin | 27 | $279 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $268 | $17 |
| Trazodone | 18 | $119 | $7 |
| Prednisone | 13 | $116 | $9 |
2020: 31 drugs
| Veltassa | 13 | $21,164 | $1,628 |
| Procrit | 15 | $19,911 | $1,327 |
| Lokelma | 17 | $12,359 | $727 |
| Januvia | 14 | $7,766 | $555 |
| Calcium Acetate | 42 | $6,522 | $155 |
| Lantus | 11 | $3,941 | $358 |
| Edarbi | 12 | $2,649 | $221 |
| Calcitriol | 54 | $2,226 | $41 |
| Metoprolol | 55 | $1,731 | $31 |
| Labetalol | 22 | $1,622 | $74 |
| Nifedipine Er | 14 | $1,310 | $94 |
| Amlodipine Besylate | 131 | $1,258 | $10 |
| Furosemide | 127 | $1,233 | $10 |
| Torsemide | 32 | $1,221 | $38 |
| Tamsulosin | 53 | $1,009 | $19 |
| Allopurinol | 45 | $936 | $21 |
| Losartan | 65 | $873 | $13 |
| Lisinopril | 103 | $775 | $8 |
| Hydralazine | 31 | $765 | $25 |
| Atorvastatin | 31 | $739 | $24 |
| Chlorthalidone | 28 | $587 | $21 |
| Famotidine | 28 | $485 | $17 |
| Levothyroxine | 15 | $371 | $25 |
| Diltiazem 24hr Er (Cd) | 12 | $276 | $23 |
| Spironolactone | 18 | $254 | $14 |
| Carvedilol | 12 | $204 | $17 |
| Gabapentin | 18 | $195 | $11 |
| Trazodone | 11 | $177 | $16 |
| Terazosin | 11 | $172 | $16 |
| Fluoxetine | 13 | $142 | $11 |
| Prednisone | 11 | $70 | $6 |
2019: 24 drugs
| Veltassa | 22 | $24,085 | $1,095 |
| Januvia | 12 | $7,226 | $602 |
| Calcium Acetate | 48 | $4,689 | $98 |
| Calcitriol | 91 | $4,307 | $47 |
| Intralipid | 13 | $3,571 | $275 |
| Labetalol | 26 | $2,305 | $89 |
| Tamsulosin | 51 | $1,712 | $34 |
| Nifedipine Er | 18 | $1,670 | $93 |
| Metoprolol | 45 | $1,652 | $37 |
| Metolazone | 13 | $1,508 | $116 |
| Furosemide | 106 | $1,231 | $12 |
| Amlodipine Besylate | 131 | $1,054 | $8 |
| Lisinopril | 104 | $992 | $10 |
| Atorvastatin | 34 | $953 | $28 |
| Losartan | 91 | $911 | $10 |
| Allopurinol | 41 | $873 | $21 |
| Chlorthalidone | 30 | $706 | $24 |
| Hydralazine | 18 | $473 | $26 |
| Torsemide | 11 | $343 | $31 |
| Famotidine | 26 | $251 | $10 |
| Levothyroxine | 12 | $212 | $18 |
| Triamterene-Hydrochlorothiazid | 13 | $204 | $16 |
| Gabapentin | 20 | $168 | $8 |
| Carvedilol | 13 | $112 | $9 |
2018: 34 drugs
| Renvela | 14 | $34,411 | $2,458 |
| Veltassa | 25 | $23,244 | $930 |
| Januvia | 17 | $12,463 | $733 |
| Calcium Acetate | 63 | $8,387 | $133 |
| Sevelamer Carbonate | 11 | $7,898 | $718 |
| Calcitriol | 119 | $4,644 | $39 |
| Bystolic | 18 | $4,245 | $236 |
| Clonidine | 13 | $2,927 | $225 |
| Labetalol | 26 | $2,170 | $83 |
| Metoprolol | 44 | $1,495 | $34 |
| Tamsulosin | 31 | $1,452 | $47 |
| Atorvastatin | 45 | $1,326 | $29 |
| Mycophenolate Mofetil | 15 | $1,055 | $70 |
| Nifedipine Er | 11 | $1,022 | $93 |
| Furosemide | 103 | $945 | $9 |
| Lisinopril | 129 | $933 | $7 |
| Chlorthalidone | 31 | $902 | $29 |
| Synthroid | 12 | $848 | $71 |
| Amlodipine Besylate | 104 | $834 | $8 |
| Losartan | 99 | $833 | $8 |
| Hydralazine | 28 | $666 | $24 |
| Potassium Chloride | 19 | $663 | $35 |
| Allopurinol | 31 | $635 | $20 |
| Valsartan | 13 | $608 | $47 |
| Levothyroxine | 20 | $556 | $28 |
| Fludrocortisone Acetate | 12 | $460 | $38 |
| Famotidine | 17 | $318 | $19 |
| Carvedilol | 16 | $197 | $12 |
| Gabapentin | 21 | $195 | $9 |
| Minoxidil | 14 | $154 | $11 |
| Triamterene-Hydrochlorothiazid | 18 | $141 | $8 |
| Hydrocodone-Acetaminophen | 11 | $128 | $12 |
| Ciprofloxacin | 14 | $89 | $6 |
| Temazepam | 13 | $61 | $5 |
2017: 42 drugs
| Sensipar | 16 | $46,257 | $2,891 |
| Renvela | 33 | $40,178 | $1,218 |
| Januvia | 20 | $13,705 | $685 |
| Veltassa | 18 | $11,581 | $643 |
| Calcium Acetate | 87 | $10,113 | $116 |
| Lyrica | 11 | $7,975 | $725 |
| Calcitriol | 101 | $4,529 | $45 |
| Clonidine | 14 | $2,580 | $184 |
| Labetalol | 34 | $2,172 | $64 |
| Valsartan | 14 | $1,842 | $132 |
| Abacavir | 11 | $1,500 | $136 |
| Tamsulosin | 32 | $1,468 | $46 |
| Atorvastatin | 54 | $1,078 | $20 |
| Nifedipine Er | 11 | $932 | $85 |
| Amlodipine Besylate | 131 | $872 | $7 |
| Metoprolol | 23 | $848 | $37 |
| Lisinopril | 131 | $839 | $6 |
| Allopurinol | 38 | $761 | $20 |
| Synthroid | 11 | $758 | $69 |
| Hydralazine | 40 | $697 | $17 |
| Mycophenolate Mofetil | 11 | $679 | $62 |
| Levothyroxine | 18 | $642 | $36 |
| Losartan | 89 | $587 | $7 |
| Furosemide | 119 | $563 | $5 |
| Midodrine | 11 | $534 | $49 |
| Chlorthalidone | 15 | $421 | $28 |
| Trazodone | 15 | $306 | $20 |
| Carvedilol | 24 | $281 | $12 |
| Triamterene-Hydrochlorothiazid | 27 | $278 | $10 |
| Spironolactone | 13 | $245 | $19 |
| Paroxetine | 15 | $207 | $14 |
| Doxazosin Mesylate | 13 | $198 | $15 |
| Terazosin | 17 | $197 | $12 |
| Famotidine | 12 | $173 | $14 |
| Warfarin | 11 | $139 | $13 |
| Mirtazapine | 12 | $131 | $11 |
| Minoxidil | 11 | $124 | $11 |
| Metoprolol | 12 | $119 | $10 |
| Hydrocodone-Acetaminophen | 13 | $116 | $9 |
| Clopidogrel | 19 | $102 | $5 |
| Hydrochlorothiazide | 11 | $101 | $9 |
| Temazepam | 11 | $56 | $5 |
2016: 40 drugs
| Sensipar | 17 | $36,355 | $2,139 |
| Renvela | 29 | $31,807 | $1,097 |
| Procrit | 12 | $8,232 | $686 |
| Lyrica | 11 | $7,172 | $652 |
| Calcium Acetate | 62 | $5,709 | $92 |
| Calcitriol | 75 | $2,933 | $39 |
| Labetalol | 24 | $2,892 | $120 |
| Clonidine | 14 | $2,380 | $170 |
| Bystolic | 13 | $2,369 | $182 |
| Omega-3 Acid Ethyl Esters | 12 | $2,213 | $184 |
| Valsartan | 18 | $1,629 | $90 |
| Lisinopril | 98 | $987 | $10 |
| Atorvastatin | 56 | $949 | $17 |
| Tamsulosin | 39 | $888 | $23 |
| Metoprolol | 23 | $867 | $38 |
| Amlodipine Besylate | 125 | $823 | $7 |
| Synthroid | 12 | $798 | $66 |
| Hydralazine | 40 | $744 | $19 |
| Chlorthalidone | 21 | $743 | $35 |
| Furosemide | 111 | $693 | $6 |
| Allopurinol | 27 | $690 | $26 |
| Losartan | 85 | $657 | $8 |
| Metolazone | 13 | $509 | $39 |
| Fludrocortisone Acetate | 26 | $484 | $19 |
| Potassium Chloride | 15 | $465 | $31 |
| Trazodone | 16 | $361 | $23 |
| Terazosin | 19 | $341 | $18 |
| Clonidine | 28 | $314 | $11 |
| Spironolactone | 17 | $285 | $17 |
| Hydrocodone-Acetaminophen | 11 | $280 | $25 |
| Metoprolol | 29 | $246 | $8 |
| Paroxetine | 19 | $242 | $13 |
| Fluticasone Propionate | 16 | $199 | $12 |
| Mirtazapine | 13 | $149 | $11 |
| Carvedilol | 11 | $118 | $11 |
| Minoxidil | 11 | $112 | $10 |
| Clopidogrel | 11 | $65 | $6 |
| Temazepam | 11 | $43 | $4 |
| Glipizide | 11 | $39 | $4 |
| Ropinirole | 12 | $31 | $3 |
2015: 41 drugs
| Sensipar | 18 | $35,263 | $1,959 |
| Renvela | 27 | $29,316 | $1,086 |
| Calcium Acetate | 49 | $6,582 | $134 |
| Januvia | 14 | $6,068 | $433 |
| Clonidine | 15 | $3,754 | $250 |
| Labetalol | 20 | $2,943 | $147 |
| Calcitriol | 54 | $2,254 | $42 |
| Metoprolol | 26 | $1,749 | $67 |
| Valsartan | 12 | $1,320 | $110 |
| Nifedipine Er | 11 | $1,115 | $101 |
| Tamsulosin | 28 | $1,076 | $38 |
| Synthroid | 12 | $756 | $63 |
| Amlodipine Besylate | 90 | $714 | $8 |
| Atorvastatin | 34 | $685 | $20 |
| Lisinopril | 78 | $631 | $8 |
| Furosemide | 99 | $629 | $6 |
| Levothyroxine | 37 | $555 | $15 |
| Proair Hfa | 11 | $552 | $50 |
| Allopurinol | 21 | $487 | $23 |
| Diltiazem Er | 11 | $474 | $43 |
| Losartan | 64 | $456 | $7 |
| Potassium Chloride | 11 | $418 | $38 |
| Hydrocodone-Acetaminophen | 15 | $374 | $25 |
| Chlorthalidone | 12 | $350 | $29 |
| Hydralazine | 18 | $339 | $19 |
| Spironolactone | 21 | $292 | $14 |
| Fludrocortisone Acetate | 19 | $265 | $14 |
| Minoxidil | 17 | $264 | $16 |
| Mirtazapine | 16 | $248 | $16 |
| Azathioprine | 13 | $242 | $19 |
| Metoprolol | 35 | $212 | $6 |
| Terazosin | 19 | $197 | $10 |
| Zolpidem | 15 | $193 | $13 |
| Nifedical Xl | 14 | $143 | $10 |
| Paroxetine | 11 | $140 | $13 |
| Trazodone | 12 | $137 | $11 |
| Clonidine | 18 | $116 | $6 |
| Omeprazole | 11 | $82 | $7 |
| Clopidogrel | 11 | $77 | $7 |
| Glipizide | 13 | $44 | $3 |
| Tramadol | 11 | $33 | $3 |
2014: 36 drugs
| Sensipar | 15 | $34,907 | $2,327 |
| Renvela | 34 | $27,562 | $811 |
| Fosrenol | 18 | $23,445 | $1,303 |
| Diovan | 37 | $6,796 | $184 |
| Calcium Acetate | 51 | $6,150 | $121 |
| Clonidine | 23 | $5,143 | $224 |
| Metoprolol | 40 | $3,387 | $85 |
| Labetalol | 30 | $3,382 | $113 |
| Norvasc | 11 | $3,026 | $275 |
| Montelukast | 16 | $1,311 | $82 |
| Nifedipine Er | 13 | $1,022 | $79 |
| Calcitriol | 23 | $941 | $41 |
| Amlodipine Besylate | 91 | $864 | $9 |
| Synthroid | 14 | $801 | $57 |
| Losartan | 45 | $758 | $17 |
| Atorvastatin | 41 | $702 | $17 |
| Lisinopril | 75 | $575 | $8 |
| Tamsulosin | 11 | $567 | $52 |
| Torsemide | 19 | $519 | $27 |
| Furosemide | 87 | $492 | $6 |
| Levothyroxine | 29 | $486 | $17 |
| Spironolactone | 25 | $466 | $19 |
| Chlorthalidone | 23 | $441 | $19 |
| Diltiazem Er | 12 | $341 | $28 |
| Mirtazapine | 19 | $280 | $15 |
| Carvedilol | 11 | $276 | $25 |
| Terazosin | 23 | $271 | $12 |
| Allopurinol | 25 | $199 | $8 |
| Hydrocodone-Acetaminophen | 11 | $182 | $17 |
| Clonidine | 14 | $177 | $13 |
| Omeprazole | 17 | $139 | $8 |
| Metoprolol | 20 | $135 | $7 |
| Tramadol | 18 | $82 | $5 |
| Lorazepam | 13 | $71 | $5 |
| Gabapentin | 11 | $66 | $6 |
| Temazepam | 12 | $62 | $5 |
2013: 34 drugs
| Renvela | 32 | $20,015 | $625 |
| Fosrenol | 12 | $11,526 | $961 |
| Diovan | 30 | $4,801 | $160 |
| Calcium Acetate | 50 | $4,726 | $95 |
| Labetalol | 29 | $4,488 | $155 |
| Metoprolol | 45 | $4,460 | $99 |
| Clonidine | 16 | $2,982 | $186 |
| Norvasc | 12 | $2,645 | $220 |
| Atorvastatin | 63 | $2,487 | $39 |
| Nifedipine Er | 16 | $1,403 | $88 |
| Amlodipine Besylate | 94 | $1,015 | $11 |
| Losartan | 34 | $893 | $26 |
| Oxybutynin Chloride Er | 11 | $876 | $80 |
| Dyrenium | 11 | $751 | $68 |
| Lisinopril | 66 | $613 | $9 |
| Diltiazem Er | 13 | $578 | $44 |
| Furosemide | 73 | $419 | $6 |
| Omeprazole | 30 | $341 | $11 |
| Tamsulosin | 23 | $297 | $13 |
| Clonidine | 18 | $296 | $16 |
| Carvedilol | 18 | $274 | $15 |
| Simvastatin | 17 | $269 | $16 |
| Glipizide | 18 | $261 | $14 |
| Hydralazine | 12 | $248 | $21 |
| Levothyroxine | 12 | $216 | $18 |
| Metoprolol | 20 | $199 | $10 |
| Pantoprazole | 11 | $197 | $18 |
| Allopurinol | 12 | $140 | $12 |
| Tramadol | 25 | $119 | $5 |
| Trazodone | 14 | $106 | $8 |
| Terazosin | 12 | $102 | $9 |
| Lorazepam | 13 | $94 | $7 |
| Temazepam | 11 | $66 | $6 |
| Gabapentin | 12 | $63 | $5 |
Money from drug and device companies
$200 in 2025
| 2025 | 3 | 5 | None | $200 |
| 2024 | 2 | 2 | None | $51 |
| 2023 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $117 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $43 | 2 payments
|
| Travere Therapeutics | Filspari | $41 | 2 payments
|
See all 5 published payments
| Travere Therapeutics | Meals · 2025-12-02 | None | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-23 | Kerendia | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-17 | Kerendia | $18 |
| Travere Therapeutics | Meals · 2025-02-27 | Filspari | $33 |
| Baxter Healthcare | Meals · 2025-01-29 | None | $117 |
See earlier years (2024, 2023)
2024: $51
| Lilly USA | Jardiance | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $25 | 1 payment
|
2023: $24
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457317729
- Licence
- CA A99752California A99752: Current · expires 2027-03-31
- Trained
- University of Vermont College of Medicine, 2001 · 25 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A997520
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2100 Webster St, Suite 405, San Francisco, CA, 94115
- NPI first listed
- 2006-04-25
- NPI last updated
- 2013-07-18
This is when the NPI record was last certified, not a medical board exam.